Ruth Gong Li is currently pursuing a PhD within the field of radionuclide therapy against cancer; an industrial PhD project that is a joint collaboration between The University of Oslo, Oslo University Hospital, and the Norwegian company Oncoinvent AS. She holds a M.Sc. degree in Nanotechnology from the Norwegian University of Science and Technology.